New Multimodality Cardiac Imaging Guidelines for Competitive Athletes Created. ASE SCCT and SCMR recommendations for imaging, screening atheletes.
News | Cardiac Imaging | May 11, 2020
New Multimodality Cardiac Imaging Guidelines for Competitive Athletes Created
May 11, 2020 – Competitive athletes are a rapidly growing population worldwide. Habitual vigorous exercise, a defining...
read more
​​​​​​​American College of Cardiology, ACC, NCDR Chest Pain MI and CathPCI Registries Collect COVID-19 Data
News | Coronavirus (COVID-19) | May 11, 2020
​​​​​​​American College of Cardiology Registries Collect COVID-19 Data
May 11, 2020 — The American College of Cardiology (ACC) will begin collecting COVID-19 (SARS-CoV-2) data through the...
read more
The global, prospective, non-randomized UNTOUCHED study evaluated the safety and efficacy of the Boston Scientific Emblem S-ICD System – the only approved implantable defibrillator without wires touching the heart – for primary prevention of sudden cardiac death specifically in patients with a left ventricular ejection fraction (LVEF) ≤35 percent, the most common population to be indicated for ICD therapy. #Heartrhythm2020 #HRS20 #HRS2020
News | Implantable Cardioverter Defibrillator (ICD) | May 08, 2020
UNTOUCHED Trial Data Underscores Safety And Efficacy Of Boston Scientific S-ICD System
May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD)...
read more
The Swiss-AF study shows High Incidence Of Silent Brain Infarcts Found in Anticoagulated Atrial Fibrillation Patients. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation | May 08, 2020
High Incidence Of Silent Brain Infarcts Found in Anticoagulated Atrial Fibrillation Patients
May 8, 2020 – A new clinical study found that patients with atrial fibrillation (AF) experienced a high incidence of...
read more
PINNACLE FLX Study of New Watchman FLX LAA Occluder Meets Safety and Efficacy Endpoints. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation | May 08, 2020
PINNACLE FLX Study of New Watchman FLX LAA Occluder Meets Safety and Efficacy Endpoints 
May 8, 2020 — Positive 12-month results were announced today from the PINNACLE FLX clinical trial assessing the safety...
read more
The SERF VT EFS is a groundbreaking, single-arm observational study designed to evaluate the safety and effectiveness of the Thermedical Durablate catheter to treat VT. #HRS20 #HRS2020 #heartrhythm2020
News | Ablation Systems | May 08, 2020
Saline Enhanced Radiofrequency Ablation May be an Effective Method to Treat Ventricular Tachycardia
May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF...
read more
The first-in-human results show positive results for Medtronic's pulsed field ablation in safety and efficiency. #Heartrhythm2020 #HRS2020 #HRS20
News | Atrial Fibrillation | May 08, 2020
Pulsed AF Trial Shows Pulsed Field Ablation May be Safer Than Traditional RF Ablations
May 8, 2020 — New clinical trial reveals the first-in-human results for paroxysmal or persistent atrial fibrillation (...
read more
The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 08, 2020
Head-to-head Comparison Shows Subcutaneous ICDs Safer Than Transvenous Defibrillators 
May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable...
read more
The Affera Inc. pulsed field (PF) energy radiofrequency ablation system. First-in-human trial shows new point-by-point approach provides increased flexibility and efficiency for physicians treating arrhythmia patients. #HRS #HRS2020 #HRS20 #heartrhythm20

The Affera Inc. pulsed field (PF) energy radiofrequency ablation system.

Feature | Ablation Systems | May 08, 2020
Pulsed Field Ablation Successfully Treats Atrial Fibrillation
May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or...
read more
Necklace Patient Monitor Detects Abnormal Heart Rhythm. An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC). This wearable necklace ECG monitor provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation and is accurate, according to a new study from the University of Eastern Finland.

This wearable necklace ECG monitor provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation and is accurate, according to a new study from the University of Eastern Finland.

News | Wearables | May 08, 2020
Necklace Monitors ECG and Detects Abnormal Heart Rhythms
May 2020 — An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on...
read more
Videos | Coronavirus (COVID-19) | May 07, 2020
VIDEO: CT and POCUS Emerge As Frontline Cardiac Imaging Modalities in COVID-19 Era
Interview with Geoffrey Rose, M.D., president of Sanger Heart and Vascular Institute with Atrium Health, in Charlotte,...
read more
FDA Clears Dapagliflozin to Treat Heart Failure With Reduced Ejection Fraction. This was based on data from the DAPA-HF Trial. John McMurray, M.D., presenting the DAPA-HF Trial at AHA 2019 last November. It was part of the late-breaking presentations in the "Outside the Box: New Approaches to CVD Risk Reduction" session. Photo by AHA/Phil McCarten

John McMurray, M.D., presenting the DAPA-HF Trial at AHA 2019 last November. It was part of the late-breaking presentations in the "Outside the Box: New Approaches to CVD Risk Reduction" session. Photo by AHA/Phil McCarten

Feature | May 06, 2020
FDA Clears Dapagliflozin to Treat Heart Failure With Reduced Ejection Fraction
May 6, 2020 — The U.S. Food and Drug Administration approved AstraZeneca’s dapagliflozin (Farxiga) oral tablets for...
read more
ESC Congress Goes Virtual Amid COVID-19 Concerns. #ESC #ESCcongress
News | ESC | May 06, 2020
ESC Congress Goes Virtual Amid COVID-19 Concerns
May 6, 2020 — The European Society of Cardiology (ESC), one of the world's largest cardiovascular conferences, is...
read more
EuroPCR Cancels Annual Meeting Due to COVID-19. #SARScov2 #COVID19
News | EuroPCR | May 05, 2020
EuroPCR Cancels Annual Meeting Due to COVID-19
May 5, 2020 — The large European interventional cardiology conference EuroPCR has been cancelled due to the contenting...
read more
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Chest CT findings of pediatric patients with COVID-19 on transaxial images. (a) Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe

Chest CT findings of pediatric patients with COVID-19 on transaxial images. Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe. Image courtesy of Radiology: Cardiothoracic Imaging

News | Coronavirus (COVID-19) | May 05, 2020
Radiology: Cardiothoracic Imaging Releases New COVID-19 Findings in Children
May 5, 2020 — Children and teenagers with COVID-19 showed distinctive clinical and computed tomography (CT) findings,...
read more
© Copyright Wainscot Media. All Rights Reserved.